FAERS database collects adverse events submitted by pharmaceutical companies, clinicians, and patients. Concomitant use of statins and dipeptidyl peptidase-4 inhibitors (DPP4-is) does not appear to ...

Over 250,000 Genotypes Performed to Help Identify Individual Risk of Statin Induced Myopathy; Data Confirm Research Findings of Risk Prevalence for Statin Side Effects FRAMINGHAM, Mass., Boston Heart ...

Please provide your email address to receive an email when new articles are posted on . Although lipid-lowering medications are generally well tolerated, rare complications can include ...

Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes. Researchers at the University of Oxford, in collaboration with other researchers, ...

Immune-mediated necrotizing myopathy typically presents with progressive symmetrical proximal muscle weakness and myalgias, although some cases can present with respiratory and esophageal muscle ...

The Physicians’ Desk Reference for Herbal Medicines has a discussion of how the statins may inhibit natural synthesis of coenzyme Q, placing a patient at risk for statin myopathy. Has a benefit been ...

June 14, 2010 (Nottingham, United Kingdom) — A detailed epidemiological study of more than two million patients in the UK has found no risk of cancer associated with the use of statins [1]. Overall, ...

Active ingredient: Fenofibric acid (as choline fenofibrate) 45 mg, 135 mg; delayed-release caps. Indications: Adjunct to diet: In combination with a statin, to reduce triglycerides (TG) and increase ...

A new study from the University of Hong Kong found that statins effectively lowered all-cause and cardiovascular deaths among older adults. Statins control the production of “bad” cholesterol, ...